ARTICLE | Distillery Therapeutics
Therapeutics: BCL2-associated athanogene 3 (BAG3; CAIR-1)
January 14, 2016 8:00 AM UTC
In vitro and mouse studies suggest inhibiting BAG3 could help treat pancreatic ductal adenocarcinoma (PDAC). In human PDAC cell lines co-cultured with human or mouse macrophages, BAG3 secreted by the ...